NEWPORT BEACH, Calif., April 26 /PRNewswire/ -- Versant Ventures, a leading healthcare venture capital firm, announced that Amy Scott has been hired as an Associate effective immediately. Ms. Scott joins Versant Ventures with more than ten years of operating experience in the medical device arena. Working out of Versant's Newport Beach office, Ms. Scott will continue to focus on the medical device sector.
"Amy brings a wealth of operations and corporate strategy experience, and is a terrific addition to Versant Ventures' medical device investment concentration," commented Donald B. Milder., Managing Director, Versant Ventures. "She will provide welcome insight and perspective in the evaluation of new investments, as well as invaluable contributions in advising our portfolio companies. We are very pleased to welcome Amy to the Versant team."
Prior to Versant, Ms. Scott held multiple roles at Edwards Lifesciences (formerly Baxter Healthcare Corporation) in brand management and marketing. Ms. Scott has a proven record in managing projects from conception to launch, leading cross-functional new product development teams and driving market/profit growth. She has had extensive domestic and international experiences with Class III implantable devices, including strategic planning, business viability analyses, and business and product acquisition/expansion assessments. Most recently, she held the position of Vice President in Edwards' Global Marketing Department, responsible for strategy development and new product launches. Amy earned her Bachelor's degree in business from Indiana University and an MBA from Pepperdine University.
About Versant Ventures
Founded in 1999, Versant Ventures currently manage $680 million in committed capital. Since its formation, Versant has invested in more than 50 companies in the Medical Device, Biotech, Healthcare Services and Healthcare Information Technology sectors. The Versant team of twelve investment professionals located in Menlo Park and Newport Beach bring together more than 175 years of combined experience and success as venture capitalists and entrepreneurs. Versant invests in early-stage healthcare companies promising to be significant, long-term market leaders. Versant funds and nurtures companies with experienced entrepreneurs, a proprietary product or service with a sustainable competitive advantage, large market potential and a realistic business model. For additional information, please visit http://www.versantventures.com/.
CONTACT: Donald B. Milder, Managing Director of Versant Ventures,949-729-4500; or Karen L. Bergman or Michelle Corral, 650-575-1509 or415-794-8662, both of BCC Partners for Versant Ventures